Related Articles
Synthesis and positron emission tomography evaluation of 18F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer Corrigendum in /10.3892/ol.2015.4039
Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium
The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor
Primary prostate cancer cultures are models for androgen-independent transit amplifying cells
New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells